Pfizer Results Hurt by Pricing Challenges - The Wall Street Journal

Pfizer Results Hurt by Pricing Challenges  The Wall Street Journal

Pfizer reported a fourth-quarter loss as the pharmaceutical company faced pricing challenges in the U.S. and tougher generic competition.